NPI: 1023078466 · FREDERICK, MD 21702 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/27/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/27/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,578 | $28K |
| 2019 | 4,814 | $44K |
| 2020 | 4,457 | $90K |
| 2021 | 4,379 | $98K |
| 2022 | 3,343 | $99K |
| 2023 | 3,887 | $129K |
| 2024 | 1,852 | $74K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 13,802 | 1,146 | $414K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 7,161 | 506 | $82K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 245 | 138 | $57K |
| J1756 | Injection, iron sucrose, 1 mg | 901 | 256 | $4K |
| 83970 | 598 | 538 | $3K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 1,409 | 140 | $2K |
| A4657 | Syringe, with or without needle, each | 1,701 | 1,073 | $895.57 |
| 85041 | 976 | 916 | $0.00 | |
| 85048 | 959 | 899 | $0.00 | |
| 83540 | 517 | 490 | $0.00 | |
| 82108 | 52 | 51 | $0.00 | |
| 83550 | 454 | 431 | $0.00 | |
| 82728 | 414 | 398 | $0.00 | |
| 82607 | 29 | 28 | $0.00 | |
| 82746 | 29 | 28 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 49 | 39 | $0.00 |
| 90677 | 14 | 12 | $0.00 |